Target mechanism-based whole-cell screening identifies bortezomib as an inhibitor of caseinolytic protease in mycobacteria
10.1128/mBio.00253-15
Saved in:
Main Authors: | Moreira W., Ngan G.J.Y., Low J.L., Poulsen A., Chia B.C.S., Ang M.J.Y., Yap A., Fulwood J., Lakshmanan U., Lim J., Khoo A.Y.T., Flotow H., Hill J., Raju R.M., Rubin E.J., Dick T. |
---|---|
Other Authors: | MICROBIOLOGY AND IMMUNOLOGY |
Format: | Article |
Published: |
American Society for Microbiology
2018
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/145963 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
IDENTIFICATION OF BORTEZOMIB AS MYCOBACTERIAL CASEINOLYTIC PROTEASE INHIBITOR
by: GRACE NGAN JIE YIN
Published: (2018) -
Bortezomib warhead-switch confers dual activity against mycobacterial caseinolytic protease and proteasome and selectivity against human proteasome
by: Moreira W., et al.
Published: (2020) -
Mycobacterial caseinolytic protease gene regulator ClgR is a substrate of caseinolytic protease
by: Yamada Y., et al.
Published: (2020) -
Missense mutations in the unfoldase ClpC1 of the caseinolytic protease complex are associated with pyrazinamide resistance in Mycobacterium tuberculosis
by: Yee, M, et al.
Published: (2020) -
Fragment-based whole cell screen delivers hits against M. tuberculosis and non-tuberculous mycobacteria
by: Moreira, W, et al.
Published: (2020)